CCR5 and neoplasm: We purified CD11b+ myeloid cells from the spleen and the tumor of mice treated with CCR1 and CCR5 shRNAs or with scrambled shRNAs and tested their suppressive activity against HA specific, CD8+ T cells stimulated with the relevant peptide.